Characterization of mixtures of recombinant human cytochrome P450s as a screening model for metabolic stability in drug discovery

1. Recombinant human cytochrome P450 (rh CYP) has become an important screening model in drug metabolism studies due to the high cost of human and animal hepatic tissue. Until now, rh CYPs have been evaluated and used as separate forms, but a mixture of CYP forms comparable with the human liver could be of value in early drug discovery. 2. In the present study, rh CYP2C9, rh CYP2D6 and rh CYP3A4 co-expressed with reductase in Escerichia coli were mixed and evaluated with regards to kinetic properties (K m and V max) . Furthermore, antioxidant was added to investigate whether a free radical scavenger would affect the kinetic parameters. Results were compared with data obtained in human liver microsomes (HLM). 3. Results showed a good correlation between mixed rh CYP data and HLM data for K m and V max. K m varied < 3-fold between matrices for CYP2C9 and CYP3A4, whereas the K m for CYP2D6 varied up to 4.5-fold. V max differed up to 3-fold between matrices for the CYP forms investigated. However, the discrep...